A detailed history of Rf&L Wealth Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Rf&L Wealth Management, LLC holds 10,080 shares of ABT stock, worth $1.14 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
10,080
Previous 10,080 -0.0%
Holding current value
$1.14 Million
Previous $1.15 Billion 8.58%
% of portfolio
0.8%
Previous 0.88%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$109.52 - $120.96 $16,428 - $18,144
-150 Reduced 1.47%
10,080 $1.15 Billion
Q2 2023

Jul 27, 2023

SELL
$100.78 - $112.29 $50,390 - $56,145
-500 Reduced 4.66%
10,230 $1.12 Billion
Q1 2023

May 03, 2023

SELL
$96.86 - $114.01 $29,542 - $34,773
-305 Reduced 2.76%
10,730 $1.09 Billion
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $1.05 Million - $1.23 Million
11,035 New
11,035 $1.21 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Rf&L Wealth Management, LLC Portfolio

Follow Rf&L Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rf&L Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rf&L Wealth Management, LLC with notifications on news.